Longbow Finance SA Buys Shares of 8,490 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Longbow Finance SA bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,490 shares of the medical equipment provider's stock, valued at approximately $4,431,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Amalgamated Bank boosted its stake in Intuitive Surgical by 2.1% in the fourth quarter. Amalgamated Bank now owns 78,171 shares of the medical equipment provider's stock valued at $40,802,000 after acquiring an additional 1,592 shares in the last quarter. FourThought Financial Partners LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $1,158,000. Trifecta Capital Advisors LLC raised its holdings in Intuitive Surgical by 6.0% during the fourth quarter. Trifecta Capital Advisors LLC now owns 11,514 shares of the medical equipment provider's stock worth $6,010,000 after purchasing an additional 655 shares in the last quarter. BankPlus Trust Department purchased a new position in Intuitive Surgical during the fourth quarter worth about $28,000. Finally, Impax Asset Management Group plc increased its holdings in Intuitive Surgical by 3,759.5% in the fourth quarter. Impax Asset Management Group plc now owns 199,419 shares of the medical equipment provider's stock valued at $103,768,000 after buying an additional 194,252 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded down $17.27 during midday trading on Tuesday, hitting $573.74. 2,548,276 shares of the stock were exchanged, compared to its average volume of 1,739,679. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a market cap of $204.35 billion, a P/E ratio of 89.51, a P/E/G ratio of 5.85 and a beta of 1.39. The company has a 50 day moving average price of $567.01 and a two-hundred day moving average price of $527.27.

Analysts Set New Price Targets

A number of brokerages have issued reports on ISRG. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. Piper Sandler restated an "overweight" rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $613.10.

Insiders Place Their Bets

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $101,332.00. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,720,023. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,240 shares of company stock valued at $3,529,040 in the last ninety days. Corporate insiders own 0.80% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.